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Ibuprofen Does Not Increase Blood Pressure in Preeclampsia
Sofia Costas BSN, RNC, Sherry Hutton BSN, RN, Cindy Kenyon BSN, RNC
Providence St. Vincent Medical Center, Portland, Oregon
The aim of this IRB approved study was to 
evaluate the impact of ibuprofen on mean 
arterial pressure (MAP) in the immediate 
postpartum period of women with 
preeclampsia. 
Objective
In 2013, The American College of 
Obstetricians and Gynecologists (ACOG) 
made a recommendation to withhold 
ibuprofen in postpartum preeclamptic 
women. 
While the United States is facing an opioid 
epidemic, preeclamptic postpartum 
women are receiving a greater amount of 
narcotics for pain control because 
ibuprofen is not considered safe to use in 
the postpartum period. The belief is that 
ibuprofen increases blood pressure in 
postpartum women with preeclampsia. 
Background
A query identified 633 preeclamptic perinatal 
patients who delivered at Providence St. Vincent 
Medical Center, from January 2017 to December 
2017, who had severe hypertension (HTN) (BP 
>160/105) during their hospital stay. 
A total of 169 patients met our criteria, 66 (39%) 
received ibuprofen and 103 (61%) did not. 
A stratified random sample selected 60 
preeclamptic postpartum patients, including 30 
who received ibuprofen postpartum and 30 who 
did not.
Inclusion Criteria:
• Preeclampsia diagnosis
• Magnesium sulfate during the postpartum period
• Treatment for severe HTN after delivery
Exclusion Criteria:
• Patients presenting with a BP ≥160/105 at 2 
hours following delivery
The baseline MAP was obtained at 2 hours 
postpartum and the MAPs for each 24 hour 
interval were averaged. The MAPs were 
compared in women who received ibuprofen 
versus those who did not. T-tests were used to 
determine statistical significance between the 
MAPs of the two groups of patients at the 
following hourly intervals: 24, 48, 72 and 96.
Power calculations were done to ensure 
adequate sample size.
Methods
Implications for Nursing 
Practice
The average MAP scores are displayed 
in Figure 1 and Graph 1. When patients 
who did receive ibuprofen were 
compared with patients who did not 
receive ibuprofen, there was no statistical 
significant differences in MAP 
comparisons (baseline [p=0.46], 2 to 24 
hours [p=0.46], 24 to 48 hours [p=0.56], 
48 to 72 hours [p=0.45], 72 to 96 hours 
[p=0.49], average of total hours [p=0.48]).
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Average MAP Values with Standard Deviation
Ibuprofen 2 Hour Baseline 2 to 24 Hours 24-<48 Hours 48-<72 Hours 72-96 Hours Total Average
NO 98.6 ± 7.1 97.1 ± 6.4 95.1 ± 7.4 98.0 ± 8 97.8 ± 6.4 97.2  ± 7.3
YES 96.8 ± 9.9 95.9 ± 6.4 95.6 ± 7.4 96.4 ± 7.0 97.7 ± 6.8 96.5  ± 7.5
p 0.46 0.46 0.56 0.45 0.49 0.48
Results
Figure 1.
Based on our findings, ibuprofen following birth 
is safe for patients with postpartum 
preeclampsia and should be included in the pain 
control plan in order to reduce narcotic use. 
Our results demonstrated that there was no 
significant difference in MAP for preeclampsia 
patients who received ibuprofen in the 
postpartum period compared to the patients who 
did not receive ibuprofen. This finding is 
consistent with current literature. 
Since the completion of our study, the Perinatal 
Special Care Unit at Providence St. Vincent 
Medical Center has increased the percentage of 
ibuprofen administered to preeclamptic 
postpartum women from 39% to 95%. Graph 2.
Key limitations of this study included the limited 
sample size that met criteria. Demographic data 
was not collected on the patients included in this 
study.  
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